Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Kerr

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Gene profiling in early stage diseaseRachel Midgley, Kakil Rasul, Haitham Al Salama, et al.
Trends in Cancer|October 2, 2024
Accessing the vasculature in cancer: revising an old hallmarkAdrian L Harris, David J Kerr, Francesco Pezzella, et al.
Current Pharmaceutical Design|October 8, 2003
CB 1954: from the Walker tumor to NQO2 and VDEPTRichard J Knox, Philip J Burke, Shiuan Chen, et al.
Nature Chemical Biology|June 19, 2009
Open access chemical and clinical probes to support drug discoveryAled M Edwards, Chas Bountra, David J Kerr, et al.
Nature Reviews. Clinical Oncology|November 24, 2023
Personalizing adjuvant therapy for patients with colorectal cancerLi Yang, Jinlin Yang, Andreas Kleppe, et al.
Gastroenterology Report|June 21, 2019
Challenges and solutions in patient treatment strategies for stage II colon cancerSusan Fotheringham, Guy A Mozolowski, Eleanor M A Murray, et al.
Nature Reviews. Clinical Oncology|September 24, 2014
Clinical cancer research: the past, present and the futureVincent T DeVita, Alexander M M Eggermont, Samuel Hellman, et al.
Clinical Colorectal Cancer|June 5, 2003
A trial of adjuvant therapy in colorectal cancer: the VICTOR trialStuart Pendlebury, Francesca Duchesne, Katharine A Reed, et al.
Methods in Molecular Medicine|December 6, 2003
The nitroreductase/CB1954 enzyme-prodrug systemNicola K Green, David J Kerr, Vivien Mautner, et al.
Lancet (London, England)|December 18, 2007
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study, Richard Gray, Jennifer Barnwell, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Gene profiling in early stage diseaseRachel Midgley, Kakil Rasul, Haitham Al Salama, et al.
Trends in Cancer|October 2, 2024
Accessing the vasculature in cancer: revising an old hallmarkAdrian L Harris, David J Kerr, Francesco Pezzella, et al.
Current Pharmaceutical Design|October 8, 2003
CB 1954: from the Walker tumor to NQO2 and VDEPTRichard J Knox, Philip J Burke, Shiuan Chen, et al.
Nature Chemical Biology|June 19, 2009
Open access chemical and clinical probes to support drug discoveryAled M Edwards, Chas Bountra, David J Kerr, et al.
Nature Reviews. Clinical Oncology|November 24, 2023
Personalizing adjuvant therapy for patients with colorectal cancerLi Yang, Jinlin Yang, Andreas Kleppe, et al.
Gastroenterology Report|June 21, 2019
Challenges and solutions in patient treatment strategies for stage II colon cancerSusan Fotheringham, Guy A Mozolowski, Eleanor M A Murray, et al.
Nature Reviews. Clinical Oncology|September 24, 2014
Clinical cancer research: the past, present and the futureVincent T DeVita, Alexander M M Eggermont, Samuel Hellman, et al.
Clinical Colorectal Cancer|June 5, 2003
A trial of adjuvant therapy in colorectal cancer: the VICTOR trialStuart Pendlebury, Francesca Duchesne, Katharine A Reed, et al.
Methods in Molecular Medicine|December 6, 2003
The nitroreductase/CB1954 enzyme-prodrug systemNicola K Green, David J Kerr, Vivien Mautner, et al.
Lancet (London, England)|December 18, 2007
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study, Richard Gray, Jennifer Barnwell, et al.
Pageof 12